TRxADE HEALTH Enters Material Agreement, Completes Asset Acquisition
Ticker: SCNX · Form: 8-K · Filed: Feb 16, 2024 · CIK: 1382574
| Field | Detail |
|---|---|
| Company | Trxade Health, Inc (SCNX) |
| Form Type | 8-K |
| Filed Date | Feb 16, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $22.5 m, $1.6 million, $7.5 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, material-agreement, corporate-action
TL;DR
**TRxADE HEALTH just made a big move, signing a key agreement and completing an acquisition on February 16, 2024!**
AI Summary
TRxADE HEALTH, INC. filed an 8-K on February 16, 2024, reporting an entry into a material definitive agreement and the completion of an acquisition or disposition of assets. The filing indicates a significant corporate event, likely a merger or acquisition, given the dual reporting items. The company, based in Lutz, FL, operates in wholesale drugs and has a business phone of (800) 261 0281.
Why It Matters
This filing signals a major strategic shift for TRxADE HEALTH, potentially impacting its market position, financial performance, and future growth trajectory through new assets or liabilities.
Risk Assessment
Risk Level: medium — The filing indicates a significant corporate transaction (acquisition/disposition and material agreement) which inherently carries integration and financial risks, but the specific details are not provided to assess the full impact.
Key Players & Entities
- TRxADE HEALTH, INC. (company) — Registrant
- February 16, 2024 (date) — Date of earliest event reported
- Delaware (location) — State of incorporation
- 001-39199 (number) — Commission File No.
- 2420 Brunello Trace, Lutz, FL 33558 (location) — Business Address
FAQ
What was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 16, 2024.
What specific items did TRxADE HEALTH, INC. report in this 8-K?
TRxADE HEALTH, INC. reported an "Entry into a Material Definitive Agreement" and "Completion of Acquisition or Disposition of Assets" in this 8-K filing.
What is the state of incorporation for TRxADE HEALTH, INC.?
TRxADE HEALTH, INC. is incorporated in Delaware.
What is the business address of TRxADE HEALTH, INC. as listed in the filing?
The business address of TRxADE HEALTH, INC. is 2420 Brunello Trace, Lutz, FL 33558.
What is the Commission File Number for TRxADE HEALTH, INC.?
The Commission File Number for TRxADE HEALTH, INC. is 001-39199.
Filing Stats: 1,112 words · 4 min read · ~4 pages · Grade level 10.6 · Accepted 2024-02-16 17:05:42
Key Financial Figures
- $22.5 m — hase Agreement to be paid at closing is $22.5 million, subject to customary adjustments
- $1.6 million — ersary of the closing date MMS receives $1.6 million or greater in certain collections from
- $7.5 million — Trxade, Inc. will be due an additional $7.5 million payment from MMS. The Purchase Agreem
Filing Documents
- form8-k.htm (8-K) — 49KB
- ex2-1.htm (EX-2.1) — 658KB
- 0001493152-24-007038.txt ( ) — 991KB
- meds-20240216.xsd (EX-101.SCH) — 3KB
- meds-20240216_lab.xml (EX-101.LAB) — 33KB
- meds-20240216_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TRxADE HEALTH, INC. By: /s/ Suren Ajjarapu Suren Ajjarapu Chief Executive Officer Date: February 16, 2024